Clinical Trial Update: L-ornithine L-aspartate in Overt Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

This update reports completion of a Phase 4 trial evaluating L-ornithine L-aspartate for overt hepatic encephalopathy in patients with cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Dayanand Medical College and Hospital | Conditions: Cirrhosis of Liver, Hepatic Encephalopathy | Phase 4 | Status: COMPLETED